October Pharma S.A.E (EGX:OCPH)

Market Cap	1.63B
Revenue (ttm)	1.34B
Net Income (ttm)	138.41M
Shares Out	12.00M
EPS (ttm)	11.53
PE Ratio	11.79
Forward PE	n/a
Dividend	2.50 (1.84%)
Ex-Dividend Date	n/a

Volume	30,183
Average Volume	4,314
Open	124.67
Previous Close	124.67
Day's Range	129.60 - 148.00
52-Week Range	85.00 - 166.99
Beta	0.10
RSI	78.04
Earnings Date	Aug 14, 2025

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.